Instituto Português de Oncologia de Lisboa Francisco Gentil: Difference between revisions

From Beacon
Line 132: Line 132:


'''Access Information:''' Information [https://www.ipolisboa.min-saude.pt/apoio-e-servicos/lar-de-doentes/].
'''Access Information:''' Information [https://www.ipolisboa.min-saude.pt/apoio-e-servicos/lar-de-doentes/].
=== Tool: MyIPO Lisboa ===
'''Primary purpose:''' To provide patients with easy access to their medical information, schedules, treatments, exams, reports, and other essential services, enhancing communication and interaction with the institute and its health professionals.
'''Access Information:''' Information [https://www.ipolisboa.min-saude.pt/myipo-lisboa/].
</div>
</div>

Revision as of 17:24, 11 August 2023

Experts

Learning Resources

Primary purpose:

Target audience:

Information:

Primary purpose:

Target audience:

Information:

Primary purpose:

Target audience:

Information:


Cancer-related Patient Associations and Resources

Resource: Information Brochures

Primary purpose: Offers information and guidance to patients, about cancer treatments, consultations, nutrition, etc.

Access Information: Information [1].

Association: Acreditar - Association of parents and friends of children with cancer

Primary purpose: To offer a range of support services to children with cancer and their families, including emotional assistance, practical help, and accommodation during treatments.

Access Information: Information [2].

Facility: Patient Home

Primary purpose: To provide accommodation and support for patients who require consultations, tests, or long-term treatments that do not require hospitalization, ensuring their comfort and well-being throughout the treatment process.

Access Information: Information [3].

Tool: MyIPO Lisboa

Primary purpose: To provide patients with easy access to their medical information, schedules, treatments, exams, reports, and other essential services, enhancing communication and interaction with the institute and its health professionals.

Access Information: Information [4].